Biotechnology leads the charge with 15+ stocks (BMRN, BNTX, JAZZ) recently rated strong buy by analysts on Wednesday. Large-cap names NUE, WAB, and OKE also secured bullish upgrades through Thursday. Aggressive price targets for SPOT and NFLX indicate robust consumer tech momentum with significant upside. However, a Thursday downgrade for ADBE and PG suggests a tactical shift away from software and defensive staples.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.